Endocrinology
News from the FDA/CDC
FDA okays first-ever new drug for rare bone disorder
The drug reduced annualized heterotopic ossification volume by 54%.
Latest News
Skin reactions common at insulin pump infusion sites
The inflammatory response “may result in tissue changes responsible for the infusion-site failures seen frequently in clinical practice,” say the...
Latest News
The fertile future of fertility technology
Fertility treatments involve endless analysis, diagnosis, and recommendations.
From the Journals
Pregnancy risks elevated in women with chronic pancreatitis
Pregnancies with chronic pancreatitis were associated with longer hospital stays and higher hospital costs.
From the Journals
Stiff arteries may cause metabolic syndrome
“It seems metabolic syndrome has a new risk factor we haven’t thought about.”
Feature
Could GLP-1 receptor agonists ease knee osteoarthritis pain, slow progression?
Weight loss is recommended for patients with knee osteoarthritis (KOA), and GLP-1 RAs are approved for weight loss. Early research suggests these...
Latest News
In new era of gene therapy, PCPs are ‘boots on the ground’
Pediatricians and general practitioners will be central to finding and monitoring the patients that need these treatments.
From the Journals
USPSTF maintains ‘insufficient evidence’ for lipid disorder screenings in kids and teens
“There’s just not enough evidence to determine whether or not screening all children for high cholesterol improves their heart health into...
Commentary
10 ways docs sabotage their patients’ weight loss journeys
Stopping medications for obesity when weight is lost. Do you also stop blood pressure medications when they normalize a patient’s blood pressure...
From the Journals
Meta-analysis finds increase in type 1 diabetes incidence, ketoacidosis during COVID pandemic
Data reported in 15 studies showed a 26% increase in DKA incidence during the first year of the pandemic.
News from the FDA/CDC
FDA approves first over-the-counter birth control pill
The product, OPill, is expected to be available early in 2024.